BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2129379)

  • 1. Altered rheological properties of blood following administrations of tissue plasminogen activator and streptokinase in patients with acute myocardial infarction.
    Jan KM; Powers E; Reinhart W; Berke A; Nichols A; Watson R; Reison D; Schwartz A; Chien S
    Adv Exp Med Biol; 1990; 281():409-17. PubMed ID: 2129379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
    Rao AK; Pratt C; Berke A; Jaffe A; Ockene I; Schreiber TL; Bell WR; Knatterud G; Robertson TL; Terrin ML
    J Am Coll Cardiol; 1988 Jan; 11(1):1-11. PubMed ID: 3121710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
    Chesebro JH; Knatterud G; Roberts R; Borer J; Cohen LS; Dalen J; Dodge HT; Francis CK; Hillis D; Ludbrook P
    Circulation; 1987 Jul; 76(1):142-54. PubMed ID: 3109764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
    Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
    Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction.
    Magnani B
    J Am Coll Cardiol; 1989 Jan; 13(1):19-26. PubMed ID: 2491867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction.
    Sherry S; Marder VJ
    Ann Intern Med; 1991 Mar; 114(5):417-23. PubMed ID: 1899546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in myocardial infarction (TIMI): update 1987.
    Mueller HS
    Klin Wochenschr; 1988; 66 Suppl 12():93-101. PubMed ID: 3126350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.
    Collen D; Bounameaux H; De Cock F; Lijnen HR; Verstraete M
    Circulation; 1986 Mar; 73(3):511-7. PubMed ID: 2419009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the fibrinolytic system components during acute myocardial infarction.
    Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
    Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoepidemiology of bleeding events after use of r-alteplase or streptokinase in acute myocardial infarction.
    McLeod DC; Coln WG; Thayer CF; Perfetto EM; Hartzema AG
    Ann Pharmacother; 1993; 27(7-8):956-62. PubMed ID: 8364282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the clinical laboratory in monitoring fibrinolytic therapy of acute myocardial infarction.
    Bovill E; Triplett D; Stump D
    Hematol Pathol; 1990; 4(2):61-6. PubMed ID: 2115512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood viscosity and platelet function in thrombolytic therapy of acute myocardial infarction.
    Hoffmann JJ
    Eur Heart J; 1990 Aug; 11 Suppl F():29-35. PubMed ID: 2121489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.